GSK Plc is planning five simultaneous late-stage trials for a cancer drug it hopes will be a blockbuster, as new Chief ...

The pharma giant and medical device posts earnings and sales that beat analysts’ estimates.

Practice earns maximum quality scores on avoidable ED visits and admissions for second consecutive period; per-episode savings exceed $6,400CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The ...

At the AMCP Annual Meeting in Nashville, Abby Kim, Pharm.D., senior director of clinical strategy and oncology specialty ...

Oncology M&A activity is accelerating as large pharmaceutical companies race to replenish pipelines facing patent cliffs and ...

Certain cancer-care services will once again be available in Harvey with the completion of a new oncology center in August.

A patented, generalized drug-response foundation model trained to internalize relationships between chemical structure, tumor ...

The care that older adults with advanced cancer receive often does not align with their preferences and values, study ...

Gilead has struck a deal to buy Germany-based Tubulis for $3.15 billion upfront and up to $1.85 billion in milestones, securing an antibody-drug conjugate (ADC) candidate that is racing toward pivotal ...

Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13, ...

After researching lymphomas for more than a decade and beating the illness herself, NYU Langone professor and alum Lisa Roth ...

SHANGHAI, April 9 (Reuters) - Cambridge, Massachusetts-based oncology drugmaker Boston Oncology CGT Holding will license ...